Association Between Antibiotic and Outcomes of Chemoimmunotherapy for Extensive‐Stage Small Cell Lung Cancer: A Multicenter Retrospective Study of 132 Patients
p-ATB has no significant impact on PFS, OS, ORR, or the incidence of irAEs in ES-SCLC patients receiving chemoimmunotherapy. Similarly, c-ATB does not seem to affect PFS or OS.
Authors
- Jing Xu (ORCID: https://orcid.org/0000-0001-8084-5609)
- Fang Deng (ORCID: https://orcid.org/0000-0001-5441-6368)
- Yu Li (ORCID: https://orcid.org/0000-0003-4798-1638)
- Meiling Sun (ORCID: https://orcid.org/0000-0002-0931-0684)
- Zhongfei Yang (ORCID: https://orcid.org/0000-0001-7406-9332)
- Hong Ye
- Ping Zhang (ORCID: https://orcid.org/0009-0007-1402-0159)
Institutions
- Shandong University (CN)
- Binzhou People's Hospital (CN)
- Weihai Municipal Hospital (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1111/1759-7714.15492
- Citations
- 1
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.28